Abstract:Hepatic ischemia/reperfusion injury (IRI), an exogenous, antigen-independent, local inflammation response, occurs in multiple clinical settings, including liver transplantation, hepatic resection, trauma, and shock. The nervous system maintains extensive crosstalk with the immune system through neuropeptide and peptide hormone networks. This study examined the function and therapeutic potential of the vasoactive intestinal peptide (VIP) neuropeptide in a murine model of liver warm ischemia (90 minutes) followed by reperfusion. Liver ischemia/reperfusion (IR) triggered an induction of gene expression of intrinsic VIP; this peaked at 24 hours of reperfusion and coincided with a hepatic self-healing phase. Treatment with the VIP neuropeptide protected livers from IRI; this was evidenced by diminished serum alanine aminotransferase levels and well-preserved tissue architecture and was associated with elevated intracellular cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) signaling. The hepatocellular protection rendered by VIP was accompanied by diminished neutrophil/macrophage infiltration and activation, reduced hepatocyte necrosis/apoptosis, and increased hepatic interleukin-10 (IL-10) expression. Strikingly, PKA inhibition restored liver damage in otherwise IR-resistant VIP-treated mice. In vitro, VIP not only diminished macrophage tumor necrosis factor /IL-6/IL-12 expression in a PKA-dependent manner but also prevented necrosis/apoptosis in primary mouse hepatocyte cultures. In conclusion, our findings document the importance of VIP neuropeptide-mediated cAMP-PKA signaling in hepatic homeostasis and cytoprotection in vivo. Because the enhancement of neural modulation differentially regulates local inflammation and prevents hepatocyte death, these results provide the rationale for novel approaches to managing liver IRI in transplant patients. Liver Transpl 19:945-956, 2013. (c) 2013 AASLD.

Vasoactive Intestinal Peptide Induces Surfactant Protein A Expression In Atii Cells Through Activation Of Pkc/C-Fos Pathway

Role of c-fos gene in vasoactive intestinal peptide promoted synthesis of pulmonary surfactant phospholipids.

[Influence of Vasoactive Intestinal Peptide on Expression of Pulmonary Surfactant Associated Protein A in Lung Explants].

Effect of Vasoactive Intestinal Peptide on Pulmonary Surfactants Phospholipid Synthesis in Lung Explants

Role of c-fos gene in the pulmonary surfactant synthesis of cultured alveolar type II cells induced by endothelin-1

Vasoactive Intestinal Peptide Suppresses Macrophage-Mediated Inflammation by Downregulating Interleukin-17A Expression Via PKA- and PKC-dependent Pathways.

Vasoactive Intestinal Peptide Inhibits the Activation of Murine Fibroblasts and Expression of Interleukin 17 Receptor C

Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation

The Role of Vasoactive Intestinal Peptide in Pulmonary Diseases

Affection of Epidermal Growth Factor on VIP Secretion and VIPR Expression in Airway Epithelial Cells

Activation of CFTR trafficking and gating by vasoactive intestinal peptide in human bronchial epithelial cells.

[Effects of Vasoactive Intestinal Peptide on the Enzyme Activity of CTP: Phosphorylcholine Cytidylyltransferase from the Rat Lung].

Establishment of Surfactant-Associated Protein a Suicide Gene System and Analysis of Its Activity

Upregulation of Surfactant Synthesis Triggers ABCA1-mediated Basolateral Phospholipid Efflux.

Surfactant protein A regulates the expression of MIP-2 and inhibits NF-κB binding activity in tubular epithelial cells

Protection of vasoactive intestinal peptide on lung injury induced by endotoxic shock in rats

Surfactant Protein A, a Novel Regulator for Smooth Muscle Phenotypic Modulation and Vascular Remodeling-Brief Report

Vasoactive Intestinal Peptide Attenuates Liver Ischemia/reperfusion Injury in Mice Via the Cyclic Adenosine Monophosphate-Protein Kinase a Pathway.

Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro

Vasoactive Intestinal Peptide Re-Balances TREM-1/TREM-2 Ratio in Acute Lung Injury

Vasoactive intestinal peptide attenuates bleomycin-induced murine pulmonary fibrosis by inhibiting epithelial-mesenchymal transition: Restoring autophagy in alveolar epithelial cells